Qitan Tech Raises RMB 700 Million in Series C Financing Led by Meituan
Qitan Tech, a nanopore gene sequencer maker based in Chengdu, has reportedly raised RMB 700...
Kanghong’s Escitalopram Oral Solution Receives NMPA Marketing Approval
China-based Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE: 002773) has announced receiving marketing approval from...
Tonghua Dongbao Receives NMPA Approval for THDBH151 Clinical Study in Gout and Hyperuricemia
China-based Tonghua Dongbao Pharmaceuticals (SHA: 600867) has announced receiving approval from the National Medical Products...
Innovent Biologics Announces Strategic Partnerships to Form Tumor Diagnosis and Treatment Alliance
China-based Innovent Biologics (HKG: 1801) has announced a series of strategic partnerships with compatriot firms...
BioNTech Ships First COVID-19 Vaccine Batches to China
BioNTech is reportedly in the process of shipping the first batches of its COVID-19 vaccines...
Merck Launches Noxafil in China for Antifungal Treatment
US-based Merck, Sharp & Dohme Inc. (MSD, NYSE: MRK) has announced the official market launch...
Hinova’s PROTAC Drug HP518 Accepted for FDA Review in mCRPC
China-based biopharma Hinova Pharmaceuticals has announced that a clinical trial filing for its androgen receptor...
Fosun Kite’s CAR-T Therapy FKC889 Approved for Clinical Trials in China
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced that its...
Shanghai Outlines Plans to Boost Healthcare and Pharma Industry
Liu Wei, director of the market orders and trade division of the Shanghai Commerce Commission,...
Yantai Dongcheng Receives NMPA Approval for F18 PET Imaging Study
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) has announced receiving approval from the...
Biomica Raises Funds for Tumor Immunity and IBD Drug Development
Israel-based start-up Biomica has reportedly raised an undisclosed amount of money via another financing round,...
Redpine Medical Raises ‘Hundreds of Millions’ in Series C Financing Round
Redpine Medical, a single-use endoscope maker based in Guangzhou, has reportedly raised “hundreds of millions”...
Yipinhong’s AR882 Receives NMPA Approval for Gout Clinical Trial
China-based Yipinhong Pharmacy Co., Ltd (SHA: 300723) has announced that its pipeline candidate AR882, under...
Shaanxi Panlong Receives Patents for Coronavirus 3CL Protease Inhibitor
China-based Shaanxi Panlong Pharmaceutical Group Co., Ltd (SHE: 002864) has announced receiving two patents (US11518759B1,...
Sibionics Raises RMB 500 Million in Series D Financing Round
Shenzhen-based chronic disease device maker Sibionics has reportedly raised close to RMB 500 million (USD...
Waker Bioscience Raises Angel Funding for ISA Technology Upgrades
Waker Bioscience, an integration site analysis (ISA) specialist based in Shanghai, has reportedly raised “tens...
InnoCare Receives CDE Approval for Phase II Trial of Orelabrutinib Combination
China-based biopharma InnoCare Pharma (HKG: 9969, SHA: 688428) has announced receiving approval from China’s Center...
Ronovo Surgical Raises Pre-Series B Funding for Surgical Robot Development
Ronovo Surgical, a minimally invasive surgery device maker based in Shanghai, has reportedly raised “tens...
PingAn Good Doctor Partners to Establish Lifestyle Medicine
China-based PingAn Healthcare and Technology Co., Ltd (HKG: 1833), also known as PingAn Good Doctor,...
JW Therapeutics Collaborates with Juno for DLL3 CAR-T Therapy Development
China-based JW Therapeutics Co., Ltd (HKG: 2126) has issued a stock exchange announcement revealing a...